The Quebec cannabis society (SQDC) posted net earnings of $19 million for its second quarter on Friday, up 25.4 per cent from the same period last year, which it attributed in part to the expansion of its branch network. The Crown corporation's network consisted of 77 outlets at the end of the most recent quarter, 32 more than at the same time last year.

As a result, SQDC's sales totalled $142.0 million in the second quarter, up 18 per cent from $120.2 million a year earlier.

In addition to the growth in the number of branches, the SQDC attributed the increase in revenue to the migration of consumers from the illicit market.

Cannabis sales up roughly 20 per cent as legal market cuts into illicit trade

Falling cannabis prices are taking a bite out of the illicit market in Nova Scotia, according to the province's official cannabis retailer. 

"The whole intent of legalization was to make an impact on the illicit market," said Bev Ware, a spokesperson for the Nova Scotia Liquor Corp.

Ware said the average price of a single gram of marijuana in Nova Scotia now stands at $6.50, down by nearly 40 per cent since legalization in 2018. 

But it's a stable supply of one-ounce packages of cannabis, some selling for as low as $110, "that helps compete with the illicit market," Ware said.  

With earnings season kicking into high gear for the cannabis industry, several companies that have reported earnings have seen volatile price swings.

Broker-dealers have been responding to the earnings reports by changing ratings and price targets on companies they respectively cover. Today, we highlighted several Canadian Licensed Producer (LPs) that have been the subject of rating and price target changes by broker-dealers so our readers can have a better understanding of the upside and downside potential associated with the new price targets. 

Only exception is requirement stores be minimum 60m away from schools, adjacent parks

It's been three years since cannabis was legalized in Canada and the Regina city council says it is ready to start treating pot stores like any other retail business, with a few exceptions. 

Council voted on Wednesday to approve a report that will "significantly improve" the city's cannabis retail regulations, according to city staff. 

The decision comes despite opposition from existing cannabis retailers — who are concerned about over-saturating the market — and the city's school boards. 

The global hemp seed oil market size is anticipated to reach US$ 336.1 Mn by the end of 2030. According to a study by Future Market Insights (FMI), the market will rise at an impressive 18.5% CAGR between 2020 and 2030. According to the report, the rising demand for sustainable products will drive growth in the market. The report offers a holistic market overview intended to help stakeholders get a better look and the prevailing trends and opportunities. Besides examining investment feasibility across key segments, the study also analyses threats to the market.

Marijuana legalization, whenever it arrives, will likely come with challenges.

The U.S. pot market remains illegal at the federal level, despite dozens of states passing legislation to permit it for either medical or recreational use. Full legalization could still be years away. And while there may be lots of excitement about that and removing many barriers for cannabis producers, that doesn't mean it will be a smooth ride for investors and businesses.

EDMONTON, AB, Nov. 9, 2021 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, today announced its financial and operational results for the first quarter fiscal 2022 ended September 30, 2021.

Rising Awareness Regarding the Product’s Medicinal and Therapeutic Benefits to Foster Marijuanas Market Development, Fortune Business Insights™

Companies covered in cannabis (Marijuanas) market are Aurora Cannabis Inc. (Edmonton, Canada), Tilary, Inc. (Nanaimo, Canada), Canopy Growth Corporation (Ontario, Canada), CannTrust Holdings Inc. (Vaughan, Canada), VIVO Cannabis Inc. (Greater Napanee, Canada), Cronos Group Inc. (Toronto, Canada), Jazz Pharmaceuticals (Dublin, Ireland), OrganiGram Holdings (Moncton, Canada), Lexaria Corp. (Kelowna, Canada), ABcann Medicinals, Inc. (Ontario Canada), and more players profiled.

The Canadian marijuana company no longer has confidence in its U.S. CBD assets.

What happened?

Shares of Cronos Group (NASDAQ:CRON) are tumbling 16.5% in morning trading Tuesday after the Canadian marijuana company filed a form 12b-25 with the Securities and Exchange Commission saying it would be unable to file its quarterly earnings report on time. 

Cronos said it needs more time to figure out just how big of an impairment charge it's going to take on its cannabidiol (CBD) business, but it's going to take a hit of at least $220 million to its goodwill and intangible assets.